Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($) $ in Thousands |
|
|
|
|
|
|
|
|
12 Months Ended |
Mar. 01, 2024 |
Feb. 02, 2024 |
Jan. 01, 2024 |
Feb. 10, 2023 |
Jan. 10, 2023 |
Dec. 20, 2022 |
Oct. 17, 2022 |
Feb. 25, 2021 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Reverse stock split, description |
|
|
|
|
|
1 for 100 reverse stock split
|
|
|
|
|
Net loss |
|
|
|
|
|
|
|
|
$ 8,259
|
$ 12,039
|
Cash in operating activities |
|
|
|
|
|
|
|
|
14,115
|
10,263
|
Accumulated deficit |
|
|
|
|
|
|
|
|
$ 270,714
|
$ 262,455
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
5,320,671
|
542,145
|
Equity distribution impact, description |
|
|
|
|
Because
the Company’s public float is less than $75 million, we may not sell securities over a 12 month period in an amount greater than
one-third of our public, or approximately $3.27 million, based on a share price of $2.68 on March 3, 2023.
|
|
|
|
Because the Company’s public float is less than $75 million,
we may not sell securities over a 12-month period in an amount greater than one-third of our public float.
|
|
Public float threshold |
|
|
|
|
|
|
|
|
$ 75,000
|
|
Stock issued in public offering, units |
|
|
|
2,150,000
|
|
|
4,656
|
|
|
|
Gross proceeds from issuance |
|
|
|
|
|
|
$ 4,700
|
|
|
|
Accounts receivable |
|
|
|
|
|
|
|
|
$ 300
|
|
Leasehold improvements useful lives |
|
|
|
|
|
|
|
|
Leasehold
improvements are amortized over the shorter of their estimated useful lives or the related lease term, generally five years.
|
|
Number of potentially dilutive securities |
|
|
|
|
|
|
|
|
700,000
|
700,000
|
Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Property and equipment, estimated useful lives |
|
|
|
|
|
|
|
|
3 years
|
|
Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Property and equipment, estimated useful lives |
|
|
|
|
|
|
|
|
5 years
|
|
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Commercial Customer and Government Agencies [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Concentration risk percentage |
|
|
|
|
|
|
|
|
80.00%
|
|
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Commercial Customer and Government Agencies [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Concentration risk percentage |
|
|
|
|
|
|
|
|
78.00%
|
|
Common Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Stock issued in public offering, units |
|
|
|
86,000
|
|
|
|
|
|
|
Gross proceeds from issuance |
|
|
|
$ 12,000
|
|
|
|
|
|
|
Common Stock and Prefunded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Offering costs |
|
|
|
4,800
|
|
|
|
|
|
|
Gross proceeds from issuance |
|
|
|
5,400
|
|
|
|
|
|
|
Derivative Liabilities for Common Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Offering costs |
|
|
|
700
|
|
|
|
|
|
|
Gross proceeds from issuance |
|
|
|
6,700
|
|
|
|
|
|
|
Agent Warrant Offering [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Offering costs |
|
|
|
$ 100
|
|
|
|
|
|
|
Common Stock and Series B and Series C Preferred Stock and Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Stock issued in public offering, units |
|
|
|
|
|
|
4,656
|
|
|
|
Gross proceeds from issuance |
|
|
|
|
|
|
$ 4,700
|
|
|
|
Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Stock issued in public offering, units |
|
16,000,000
|
|
|
|
|
|
|
|
|
Gross proceeds from issuance |
$ 1,030,519,000
|
|
$ 4,000
|
|
|
|
|
|
|
|
Subsequent Event [Member] | Common Stock Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Gross proceeds from issuance |
|
|
$ 500
|
|
|
|
|
|
|
|
Maxim Group LLC [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Sale of stock, description of transaction |
|
|
|
|
|
|
|
(i) the sale of shares having an aggregate offering price of $15.0 million,
(ii) the termination by either Maxim or the Company upon the provision of fifteen (15) days written notice, or (iii) February 25, 2025.
Under the terms of the 2021 Distribution Agreement, Maxim will be entitled to a transaction fee at a fixed rate of 2.0% of the gross
sales price of Shares sold under the 2021 Distribution Agreement.
|
|
|
2021 ATM Equity Distribution Agreement [Member] | Maxim Group LLC [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Offering costs |
|
|
|
|
|
|
|
$ 1,100
|
|
|
Sale of stock, description of transaction |
|
|
|
|
The Company entered into an amendment to our Equity Distribution Agreement (the “Distribution Agreement”)
with Maxim, pursuant to which the expiration date of the Distribution Agreement was extended to the earlier of: (i) the sale of shares
having an aggregate offering price of $15.0 million, (ii) the termination by either Maxim or the Company upon the provision of fifteen
(15) days written notice, or (iii) February 25, 2024. No other changes were made to the terms of the Distribution Agreement.
|
|
|
|
|
|
Distribution Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
1,317,749
|
|
Distribution Agreement [Member] | Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
Product Information [Line Items] |
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
2,471,949
|
|
1,145,200
|
|
|
|
|
|
|
|
Gross proceeds from issuance |
$ 70,000,000
|
|
|
|
|
|
|
|
|
|